G-7 Pledges to Restrain Japanese Yen
Japan's Nikkei 225 Index advanced 2.7% on Friday, ending a turbulent week at 9,207. In Hong Kong the Hang Seng Index inched up 0.1% to 22,300 and in China the Shanghai Composite Index rose 0.3% to close at 2,907.
Japan's Nikkei 225 Index advanced 2.7% on Friday, ending a turbulent week at 9,207. In Hong Kong the Hang Seng Index inched up 0.1% to 22,300 and in China the Shanghai Composite Index rose 0.3% to close at 2,907.
As people in Japan's earthquake-tsunami disaster zone deal with the additional danger of radiation from damaged nuclear reactors, nations across the globe are taking the crisis as a sign that it's time to get more aggressive in their development of safer nuclear power plants.
Amid panic about the possibility of a radioactive fallout from Japan, Geiger counters and radiation pills have been flying off the shelves, sometimes at unscrupulous prices.
As Japan's nuclear crisis deepens, Wall Street may begin to focus on a small group of almost-ignored young biotechs. Known as the bio-defense group, these firms develop products that help protect the population from radiation leaks resulting from nuclear accidents or attacks.



